Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
46.62
+0.40 (0.87%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Corcept Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,005 | 3,661 | 5,280 | 3,348 | 2,186 | 2,097 | Upgrade
|
| Market Cap Growth | -30.87% | -30.67% | 57.69% | 53.13% | 4.24% | -30.98% | Upgrade
|
| Enterprise Value | 4,479 | 3,143 | 4,739 | 2,933 | 1,787 | 1,603 | Upgrade
|
| Last Close Price | 46.62 | 34.80 | 50.39 | 32.48 | 20.31 | 19.80 | Upgrade
|
| PE Ratio | 56.85 | 37.29 | 37.78 | 31.74 | 21.59 | 18.64 | Upgrade
|
| Forward PE | 114.83 | 55.53 | 32.11 | 32.61 | 19.95 | 21.01 | Upgrade
|
| PS Ratio | 6.57 | 4.81 | 7.82 | 6.94 | 5.44 | 5.73 | Upgrade
|
| PB Ratio | 7.63 | 5.65 | 7.77 | 6.61 | 4.36 | 5.58 | Upgrade
|
| P/TBV Ratio | 7.73 | 5.65 | 7.77 | 6.61 | 4.36 | 5.58 | Upgrade
|
| P/FCF Ratio | 35.30 | 25.82 | 26.92 | 26.46 | 18.23 | 12.53 | Upgrade
|
| P/OCF Ratio | 35.25 | 25.78 | 26.63 | 26.43 | 18.17 | 12.49 | Upgrade
|
| PEG Ratio | - | - | - | - | - | 1.50 | Upgrade
|
| EV/Sales Ratio | 5.88 | 4.13 | 7.02 | 6.08 | 4.45 | 4.38 | Upgrade
|
| EV/EBITDA Ratio | 97.48 | 68.40 | 34.40 | 27.08 | 15.69 | 12.73 | Upgrade
|
| EV/EBIT Ratio | 99.98 | 70.15 | 34.60 | 27.34 | 15.87 | 12.88 | Upgrade
|
| EV/FCF Ratio | 31.59 | 22.17 | 24.16 | 23.18 | 14.90 | 9.58 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.13 | 0.13 | 0.05 | 0.00 | 0.01 | 0.00 | Upgrade
|
| Debt / FCF Ratio | 0.04 | 0.04 | 0.04 | 0.00 | 0.01 | 0.00 | Upgrade
|
| Net Debt / Equity Ratio | -0.81 | -0.81 | -0.88 | -0.84 | -0.87 | -0.89 | Upgrade
|
| Net Debt / EBITDA Ratio | -11.45 | -11.45 | -4.33 | -3.93 | -3.82 | -2.66 | Upgrade
|
| Net Debt / FCF Ratio | -3.71 | -3.71 | -3.04 | -3.36 | -3.63 | -2.00 | Upgrade
|
| Asset Turnover | 0.91 | 0.91 | 0.92 | 0.80 | 0.80 | 0.74 | Upgrade
|
| Inventory Turnover | 1.03 | 1.03 | 1.08 | 0.94 | 0.97 | 1.07 | Upgrade
|
| Quick Ratio | 2.60 | 2.60 | 3.11 | 4.05 | 6.60 | 5.31 | Upgrade
|
| Current Ratio | 2.92 | 2.92 | 3.35 | 4.39 | 6.89 | 5.61 | Upgrade
|
| Return on Equity (ROE) | 15.02% | 15.02% | 23.81% | 21.05% | 23.11% | 25.03% | Upgrade
|
| Return on Assets (ROA) | 3.34% | 3.34% | 11.71% | 11.13% | 13.98% | 15.63% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.98% | 15.32% | 54.21% | 87.09% | 87.74% | 94.15% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.70% | 6.70% | 19.60% | 20.80% | 22.00% | 33.10% | Upgrade
|
| Earnings Yield | 1.96% | 2.72% | 2.67% | 3.17% | 4.64% | 5.36% | Upgrade
|
| FCF Yield | 2.83% | 3.87% | 3.72% | 3.78% | 5.48% | 7.98% | Upgrade
|
| Buyback Yield / Dilution | -5.73% | -5.73% | -1.55% | 3.64% | 7.94% | -1.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.